Total hip replacement has now become well accepted worldwide as a means of correcting a variety of hip disorders, including those caused by severe rheumatoid arthritis (RA) and osteoarthritis (OA), severe traumatic arthritis and congenital dysplasia. In spite of progress made in terms of biomaterials and tribology, all total hip prostheses are subject to loosening.
We have investigated the effects of biomaterials on synovial cells in vitro. Synovial tissue contains at least two distinct cell populations, macrophage-like (type A) and fibroblast-like (type B) synoviocytes. 1 It is hypothesised that the particulate debris from bone cement or prosthetic materials may stimulate macrophages and adjacent proinflammatory cells to cause loosening. 2 Local proliferation of type-B synoviocytes contributes substantially to synovial hyperplasia. These cells and synovial fluid affect the inflammatory response by releasing substances such as prostaglandins, metalloproteinases, and cytokines, which regulate cellular functions within the synovial compartment and cause tissue damage. 3 These processes are regulated by a variety of cytokines and cytokine inhibitors, acting individually, synergistically or antagonistically. 4 The levels of interleukin-1 (IL-1) and interleukin-6 (IL-6) are elevated in the synovial fluid of patients with RA 5, 6 and may play an important role not only in immune responses and the activation of inflammation but also in joint destruction. 6 IL-1 is now recognised as a potent stimulator of the formation of osteoclast-like cells in murine bone-marrow cultures. 7 IL-1 but not IL-6 affects the proliferation, differentiation, and matrix synthesis of costochondral chondrocytes by an autocrine pathway. 8 Recently, Kotake et al 9 have shown that IL-6 in synovial fluid from patients with RA is at least in part responsible for joint destruction in the presence of soluble IL-6 receptors by osteoclastogenesis. Arachidonic acid is a ubiquitous fatty-acid constituent of phospholipid membranes which can be liberated by the activation of phospholipase A 2 (PLA 2 ). Released arachidonic acid is metabolised to eicosanoids via the membraneassociated cyclo-oxygenase (COX) enzymatic pathway or by various lipoxygenase (LOX) pathways to yield monohydroxyeicosatetraenoic acids, 10 leukotriene B 4 (LTB 4 ), and peptidoleukotrienes (LTC 4 , LTD 4 , and LTE 4 ). These metabolites have been shown to modulate a host of biological activities and appear to be of particular importance in the pathogenesis of inflammatory diseases such as asthma, RA, and inflammatory bowel disease. 11 In OA, synovial lining cells produce small amounts of LTB 4 12 and synovial tissue releases LTB 4 and LTC 4 in degenerative joint diseases. 13 LTB 4 stimulates osteoclastic bone resorption both in vitro and in vivo 14 and peptidoleukotrienes stimulate isolated avian osteoclast-like cells to form resorption lacunae. 15 Human type-B synoviocytes are able to express 5-LOX, 16 12-LOX, 17 15-LOX, 18 COX-1 and COX-2. Preparation of human synovial cells. OA and RA synoviocytes were isolated from fresh synovial biopsies obtained from patients with OA and RA who were undergoing synovectomy of the hip. The synovia were minced and digested with 1.5 mg/ml of collagenase-dispase, 1 mg/ ml of hyaluronidase and 0.15 mg/ml of DNase I for three to four hours at 37°C. After centrifugation, the cells were resuspended in Dulbecco's modifed Eagle's medium (DMEM) (Gibco BRL, Cergy-Pontoise, France) supplemented with 10% fetal calf serum (Gibco BRL), 4.5 g/l of D-glucose, 25mM HEPES, 100 U/ml of penicillin and 100 g/ml of streptomycin (Gibco BRL) in a humidified atmosphere containing 5% (v/v) CO 2 at 37°C. After 48 hours, non-adherent cells were removed. Adherent cells (macrophage-like and fibroblast-like synoviocytes (FLS)) were cultured in complete medium and, at confluence, were trypsinised and only FLS were passed. These cells were used between passages 4 and 8 when they morphologically resembled FLS after indirect immunofluorescence study (see Culture of human OA and RA FLS).
FLS were cultured 45 to 60 days before experimentation. This delay allowed the elimination of all possible interactions resulting from eventual preoperative treatment such as the use of non-steroidal anti-inflammatory drugs and analgesics. No patient was receiving corticotherapy or chemotherapy. Preparation of powders. Alumina (Al 2 O 3 ) powder (AP 52) was supplied by Aluminium Pechiney (Gardanne, France). It was calcined at 1550°C for 45 minutes. For characterisation, a small fraction was analysed by SEM. The powder is composed of agglomerates containing small grains (<2 m) (Fig. 1a) .
ZrO 2 powder of medical quality was supplied by Ceramiques Techniques Desmarquet (Evreux, France). Yttrium-oxide-stabilised ZrO 2 (2.9% molar) was granulated and calcined at 1400°C. For characterisation, a small fraction of the powder was analysed by SEM. It is composed of large spherical granulates (Fig. 1b) containing small grains (<2 m) (Fig. 1c) Cell growth was determined by counting cells and indirectly confirmed by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromure) assay as previously described. 30 Toxicity was evaluated by the lactate dehydrogenase (LDH) assay. 31 Synoviocyte culture supernatants, henceforth referred to as synoviocyte-conditioned medium, were collected, centrifuged, aliquoted and stored at -80°C. All synoviocyteconditioned media were assayed for IL-1, IL-6 and PGE 2 . Furthermore, synoviocyte cultures were collected for analysis of exogenous arachidonic acid metabolites by reversephase-high-pressure liquid chromatography (RP-HPLC). Microscopy Light microscopy. Cultured FLS were fixed in absolute ethanol and observed after glycerin mounting.
Transmission electron microscopy (TEM). Cultured FLS
were fixed in phosphate buffer at pH 7.4 containing 2.5% glutaraldehyde for 30 minutes at room temperature and washed in phosphate buffer for 15 minutes. They were then incubated in 1% osmic acid for 30 minutes at room temperature, dehydrated with an increasing ethanol gradient, and embedded in epon. They were polymerised over 48 hours at 60°C and ultrathin sections (60 nm) were prepared. Grids were examined with or without uranyl acetate-lead citrate contrast and micrographs taken in a CM10 electron microscope (Philips, Limeal-Brévannes, France). Assays conducted on conditioned medium. For IL-1, IL-6 and PGE 2 assays, the collection for conditioned medium was two days. The amounts of IL-1, IL-6 and PGE 2 in synoviocyte-conditioned media were measured by commercially available EIA kits (Cayman Chemical Company, Ann Arbor, Michigan; Immunotech and Cayman Chemical Company, respectively) as described by the manufacturer. Arachidonic acid metabolism. Exogenous (1-14 C)arachidonic acid metabolism of synoviocytes was analysed by 55 mCi/mmol) and 0.5 g of calcium ionophore A23187 were added in an ethanol solution which did not exceed 0.4% and had no effect on the metabolism of arachidonic acid. After 15 minutes at 37°C, the reaction was stopped by the addition of 0. Graph showing proliferation of human OA and RA FLS exposed to Al 2 O 3 or ZrO 2 particles. There were significant differences from unstimulated groups (*p < 0.05; **p < 0.05). were eluted at a flow rate of 2 ml/min using a tertiary methanol-acetonitrile-H 2 O gradient as previously described. 32 Radioactivity was detected at the exit of the column by a Flow One/Beta A500-Packard system (Packard Instrument Company, Rungis, France). Metabolites of (1-14 C)arachidonic acid were identified by comparing their retention times with those of synthetic standards, by coelution experiments with pure metabolites, by shift retention time studies after methylation of carboxylic functions and suppression of ultraviolet absorbance after catalytic hydrogenation. 33 Products were quantified by measuring the areas under the respective peaks. Each peak count was adjusted relative to the total radioactivity of the corresponding sample. For each incubation, the amount of every metabolite was compared with the control assay. (Fig. 2) which was confirmed by the MTT test. Under our experimental conditions, no cytotoxic effects were observed when these particles were present because there was no significant difference in toxicity produced by Al 2 O 3 and ZrO 2 compared with unstimulated cells as shown by the release of LDH (Fig. 3) . Internalisation of particles. Light-microscopic observation of a representative culture of human FLS (Fig. 4a) (Table I) . Biosynthesis of LOX and COX metabolites. As previously mentioned for Table I, all the results presented in  Tables II to V are also reported for 10 6 cells.
We observed the formation of metabolites from LOX and COX pathways after incubation of human OA FLS (Table  II, Fig. 6a ) or RA FLS (Table III) (Tables IV and V) . NDGA at 1 ⌴ had no significant effect on the production of COX metabolites but inhibited the biosynthesis of LOX metabolites (⌬6-trans-LTB 4 , LTB 4 , LTC 4 , LTE 4 , 15-HETE, 12-HETE and 5-HETE) (Tables IV and V) . Moreover, IND at 1 ⌴ had no significant effect on the production of LOX metabolites but inhibited the biosynthesis of COX metabolites, PGE 2 and (12S)-12-hydroxy-5,8,10-heptadecatrienoic acid (HHT) (Tables IV and V) . In the absence of bioceramic particles, human OA and RA FLS synthesised metabolites of arachidonic acid which increased over time. We observed a significant increase in LTC 4 and LTE 4 synthesis for OA and RA FLS (Tables II  and III , respectively) but also for LTB 4 , HHT and PGE 2 Two intragroup comparisons were made for each group; for example, group 1: 10production for RA FLS (Table III) . The presence of Al 2 O 3 and ZrO 2 small particles did not modify the biosynthesis of LOX and COX metabolites over time by human OA FLS (Table II , Figs 6b and 6c) or RA FLS (Table III) . For OA FLS, however, the inhibitory effect of NDGA on Al 2 O 3 -stimulated cells (1 month) and ZrO 2 -stimulated cells (1 month) is significantly lower for LTB 4 and 5-HETE synthesis and significantly higher for 12-HETE production than on unstimulated cells (Table IV) . Similarly, in RA FLS, the inhibitory effect on NDGA on Al 2 O 3 -stimulated cells (1 month) is significantly lower for LTB 4 and 5-HETE synthesis (Table V) . By contrast, ZrO 2 particles did not modify this inhibitory effect on LTB 4 and 5-HETE production. The difference in PGE 2 levels could be due to the difference in metabolism determined by EIA (Table I) and RP-HPLC (Tables II and III) . The former method allows quantification whereas the latter represents a semiquantitative approach to the metabolism of exogenous arachidonic acid.
Discussion
Particulate wear debris is strongly implicated in the pathogenesis of aseptic loosening of total joint prostheses. 34 Type-B synoviocytes have the morphological appearance of fibroblasts as well as the structural machinery to synthesise and secrete an impressive array of products, including proteoglycans, cytokines, arachidonic-acid metabolites and metalloproteinases. In vitro testing has shown activation of fibroblasts 35 and macrophages, as well as cell-mediator release in cell cultures incubated with different types of particle. 36 Tissue culture and cultured cell experiments have shown that cells exposed to particulate debris release a number of cytokine and prostanoid inflammatory mediators, including PGE 2 , IL-1 and IL-6.
37-41
The selective effect of cytokines on the secretion of cysteine proteinases suggests that synovial fibroblast-like cell-mediated articular degradation is a highly regulated process. IL-1 and IL-6 were involved in the activation of synovial fibroblasts to cause degradation of cartilage which occurred only when fibroblasts were in contact with cartilage. 42 Recently, immunohistochemical studies of biopsies of synovium from hips have shown positive staining for IL-1, IL-6 and abundant cytokine production by cultured synovial cells. 43 We chose to study ZrO 2 and Al 2 O 3 because they are widely used in the manufacture of arthroplasty implants. [44] [45] [46] induced by these biomaterials used in orthopaedics in order to estimate their biocompatibility and cytotoxicity in vitro as previously described on macrophages. Attachment and endocytosis of most particles are increased if the particles are coated with serum components termed opsonins. In our study, TEM showed that endocytosed Al 2 O 3 and ZrO 2 particles were present in phagolysosomes. ZrO 2 particles were surrounded by pseudopods before endocytosis. This phenomenon was seen with OA as well as RA FLS. TEM confirmed the non-toxicity of both materials because there was no spontaneous detachment of cells and FLS had normal cytoplasm and nuclei as previously described on macrophages and human osteoblasts. 50, 51 There are, however, studies in the literature which question the bio-inertness of zirconia ceramic. For example, 6 ZrO 2 particles for 1 month. Metabolites identified were PGE 2 (peak 1), ⌬6-trans-LTB 4 (peak 2), LTB 4 (peak 3), HHT (peak 4), 15-HETE (peak 5), 12-HETE (peak 6), 5-HETE (peak 7), LTC 4 (peak 8), LTE 4 (peak 9). Peak 10 is the peak of (1-14 C)arachidonic acid.
adding ZrO 2 powder provoked a relative toxicity for in vitro fibroblasts. 52 Lerouge et al 53 have shown the presence of a histocytic foreign-body reaction to ZrO 2 debris on histological sections and suggested that these particles play an important role in aseptic loosening of ceramic-ceramic total hip arthroplasties. Recently, they also suggested that loosening of ceramic cups was secondary to fragmentation of cement at the bone-prosthesis interface. 26 Under experimental conditions, Al 2 O 3 and ZrO 2 are calcined at a very high temperature in order to eliminate all volatile substances which could have a deleterious effect on cell reactivity. The calcination simulates the thermal fitting that powders undergo during industrial fabrication of prosthetic heads. For a constant number of particles, increased size generally caused increased release as measured by the eicosanoid products or cytokine levels induced by Al 2 O 3 and ZrO 2 particles ranging in diameter from 0.15 m to 10 m. 54, 55 On the other hand, the maximal effect of particle size on the alumina-induced production of reactive oxygen metabolites by human leukocytes was seen at around 3 m.
56
Generally, therapeutic strategies of arthroplasty implants include the use of osteoconductive biomaterials (calcium phosphate, coral). 57 Moreover, accurate determination of the proinflammatory role of the material to be used is essential. Murray and Rushton 58 have shown that a nontoxic material could activate inflammatory mechanisms, resulting in increased bone resorption. Our work supports the hypothesis that biomaterials can directly influence the synthesis of IL-1 and IL-6 and the production of LOX and COX metabolites in human OA or RA FLS. We chose to study Al 2 O 3 and ZrO 2 because they are widely used in the manufacture of arthroplasty implants. Under our experimental conditions, proliferation of synoviocytes slowed over time in the presence of Al 2 O 3 or ZrO 2 , but these bioceramics did not significantly increase production of IL-1, IL-6 and eicosanoids by OA or RA FLS.
Our model has the advantage of prolonged exposure of human OA or RA FLS to powders and allows us to study the possible inflammatory response (arachidonic acid metabolism, proinflammatory cytokines) that can be induced by any biomaterials used in orthopaedics.
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